TAK
Takeda Pharmaceutical Company Limited
$21.27−0.37 (−1.71%)Close Nov 18, 2026
Loading the growth chart…
Growth of $10,000
Jan 5, 2010 – Nov 18, 2026, Dividends reinvested
- Final balance
- $10,632
- CAGR
- +0.36%
- Max drawdown
- −59.60%
Trailing returns (%)
TAK's average annual return was 0.81% over the last 10 years, through Nov 18, 2026. $10,000 in TAK on Nov 18, 2016 grew to $10,840 by Nov 18, 2026, with dividends reinvested.
Total
- 1M
- +8.13%
- 3M
- +17.84%
- 6M
- +28.36%
- YTD
- +36.43%
- 1Y
- +51.17%
Per year
- 3Y
- +17.66%
- 5Y
- +10.04%
- 10Y
- +0.81%
- 15Y
- +0.62%
- Since 2010
- +0.36%
Annual returns
2026 through Nov 18
TAK returns by year
| Year | Return |
|---|---|
| 2026 through Nov 18 | +36.43% |
| 2025 | +20.46% |
| 2024 | −3.12% |
| 2023 | −8.53% |
| 2022 | +14.45% |
| 2021 | −25.11% |
| 2020 | −7.75% |
| 2019 | +17.30% |
| 2018 | −40.88% |
| 2017 | +36.91% |
| 2016 | −16.98% |
| 2015 | +20.68% |
Metrics
Since 2010| Volatility | 21.75% |
|---|---|
| Sharpe ratio | 0.13 |
| Sortino ratio | 0.17 |
| Calmar ratio | 0.01 |
| Longest drawdown | 8.8 years |
Worst drawdowns
Since 2010| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −59.6% | Jan 2018 | Oct 2022 | Not yet | 8.8 years so far |
| −27.9% | Mar 2013 | Dec 2016 | Sep 2017 | 4.5 years |
| −21.2% | Feb 2011 | Dec 2011 | Jan 2013 | 1.9 years |
| −13.7% | Mar 2010 | Jun 2010 | Aug 2010 | 5 months |
| −5.9% | Nov 2010 | Nov 2010 | Jan 2011 | 2 months |